Oncology Information Systems Market Size, and Trends Forecast 2025-2033

Market Overview:

The oncology information systems market is experiencing rapid growth, driven by rising global cancer incidence, government investments and initiatives and adoption of electronic health records (ehr). According to IMARC Group's latest research publication, "Oncology Information Systems Market Report by Product and Services (Software, Services), Application (Radiation Oncology, Medical Oncology, Surgical Oncology), End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities), and Region 2025-2033", The global oncology information systems market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.95% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Finance consulting

Grab a sample PDF of this report: https://www.imarcgroup.com/oncology-information-systems-market/requestsample

Our report includes: 

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Oncology Information Systems Market

• Rising Global Cancer Incidence: The overall growth of the cancer population globally, is an increasing factor for the Oncology Information Systems (OIS) market. With millions of new cases of cancer diagnosed each year, health systems have increasing pressure to complete and manage cancer patient information in an effective way. OIS platforms help to centralize patient records, treatment plans, follow up results and coordination across healthcare providers. The Indian Cancer Genome Atlas (ICGA), started in September 2024, provides open-access multi-omics data to drive cancer research and treatment strategies, relying on contemporary OIS to manage these large and complex datasets. There are currently more cancer cases diagnosed than ever before and large-scale systems are absolutely essential for managing this increase in data. Clearly, ongoing a cancer epidemic contributes to the expansion of the OIS market.
• Government Investments and Initiatives: Government funding and policy initiatives greatly bolster the OIS market by supporting digitization in healthcare. For example, programs such as the U.S. Cancer Moonshot, which funded an enormous amount in 2022, will promote new advanced IT systems in the context of cancer care and management. In India, NPCDCS (National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke) relishes the opportunity of digitalization of data and operational efficiency with OIS in conjunction with their early detection and treatment of the population with regard to cancer and other diseases. Programs such as this both provide a supportive regulatory environment and, of course, capital flow and lend hospitals support to build operational integrity through data systems, so hospitals will make large investments in OIS, and thereby stimulate market growth and advances in oncology care solutions upon adoption to manage patient care and hence relevant population data for oncological care.
• Adoption of Electronic Health Records (EHR): The transition from paper-based to electronic health records (EHR) is a major growth factor for the OIS market. OIS systems that interact with EHRs improve data visibility, lower error rates, and improve treatment planning. For instance, in the U.S., hospitals adopting oncology-specific EMRs from companies Varian and Elekta, have used EHRs to improve patient outcomes by eliminating inefficiencies and seamless data sharing between the radiologist and oncologist. This EHR and OIS integration encourages evidence-informed decision-making and more streamlined workflows, conforming to the growing demand for personalized cancer care. As healthcare providers increase their use of digital tools, the demand for OIS and EHR capabilities will catapult growth in the OIS market.

Key Trends in the Oncology Information Systems Market

• Integration of Artificial Intelligence (AI): Artificial intelligence is transforming the OIS market by enhancing diagnostic accuracy and treatment planning. AI-driven OIS platforms analyze vast datasets to provide personalized treatment recommendations and predict patient outcomes. For instance, RaySearch Laboratories’ RayCare system, certified in 2024 for compatibility with Varian TrueBeam accelerators, leverages AI to optimize radiation therapy planning. This trend improves clinical decision-making and reduces errors in treatment workflows. As AI adoption grows, healthcare providers increasingly rely on these systems to deliver precise, data-driven oncology care, positioning AI as a cornerstone of OIS market evolution.
• Rise of Telemedicine and Remote Monitoring: The integration of telemedicine and remote patient monitoring into OIS platforms is a significant trend, accelerated by the COVID-19 pandemic. These systems enable healthcare providers to conduct virtual consultations and monitor patients remotely, improving access to care. For example, OIS platforms now support virtual tumor boards, allowing specialists to collaborate remotely on complex cases. In the Asia-Pacific region, countries like India are adopting telemedicine-enabled OIS to address rising cancer burdens in rural areas. This trend enhances patient engagement, reduces hospital visits, and supports early detection, driving demand for advanced OIS solutions.
• Cloud-Based Solutions and Data Security: The shift toward cloud-based OIS is reshaping the market, offering scalability and cost-efficiency. Cloud platforms enable secure data storage and real-time access across healthcare facilities, improving care coordination. However, this trend also emphasizes data security due to stringent regulations like GDPR. For example, companies like Siemens Healthineers are developing cloud-based OIS with end-to-end encryption to ensure patient privacy. As healthcare providers adopt these solutions to manage growing patient data, the focus on secure, interoperable systems is driving innovation and market growth, particularly in regions with advanced healthcare infrastructure.

Leading Companies Operating in the Global Oncology Information Systems Industry:

• Accuray Incorporated
• Advanced Data Systems
• Cerner Corporation (Oracle Corporation)
• CureMD Healthcare
• Elekta
• EndoSoft LLC (Utech Products Inc.)
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• McKesson Corporation
• OPTUM Inc. (United Healthcare Services Inc.)
• RaySearch Laboratories 
• Varian Medical Systems Inc.

Oncology Information Systems Market Report Segmentation:

By Product and Services:

• Software
  • Patient Information Systems
  • Treatment Planning Systems
• Services
  • Consulting Services
  • Implementation Services
  • Maintenance Services

Software (patient information systems and treatment planning systems) represents the largest segment as it streamlines workflows by digitizing patient records, making information readily accessible to healthcare providers.

By Application:

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Medical oncology represents the leading segment due to its capability to centralize patient data, including medical history, diagnostic tests, imaging results, treatment plans, and follow-up care.

By End User:

• Hospitals and Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Hospitals and diagnostic imaging centers account for the majority of the market share owing to the rising number of cancer patients seeking effective treatment.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the oncology information systems market is attributed to the rising prevalence of cancer among the masses due to adoption of unhealthy lifestyle habits and smoking.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145